LakeShore Biopharma Co Net Tangible Assets

As of the most recent data (March 2025), YS shows a net tangible assets of $500M. That compares with $590M in the prior-year period — down 14.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, YS's net tangible assets is now $500M (was $590M) — a 14.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether LakeShore Biopharma Co is outperforming or lagging.

Tracking YS's net tangible assets over time shows whether LakeShore Biopharma Co is scaling, shrinking, or reshaping that part of the business. The current reading is $500M That compares with $590M in the prior-year period — down 14.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has LakeShore Biopharma Co's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $500M) with ownership activity and broader fundamentals.